Le Lézard
Classified in: Science and technology, Business
Subjects: ERN, ACC


STOCKHOLM, April 24, 2024 /PRNewswire/ -- 

Well positioned for the gardening season

First quarter 2024           

 Well positioned for the gardening season

"As the first quarter progressed, which is a sell-in period, sales gradually improved. We went from a cautious start among our trade partners, to a more favorable development as the gardening season now begins. The Group's organic sales declined by 11% during the quarter, coming from a record first quarter last year. The operating income amounted to SEK 1,930m (2,364). Our cost savings program is progressing as planned, with savings of SEK 185m in the quarter.

The Gardena Division achieved organic growth, driven by the watering category and hand tools in Europe. The division delivered improved operating income and higher operating margin from the sales growth and result from operational efficiency measures. In addition, good progress in North America contributed to an improved operating income. 

In the Husqvarna Forest & Garden Division, sales of robotic mowers for the professional market and battery-powered products were strong. However, sales of petrol-powered wheeled products continued on a low level, partly due to lower demand and the fact that we are proactively exiting parts of this segment in North America. 

Net sales in the Husqvarna Construction Division declined, with growth in emerging markets, but lower sales in Europe and North America. The operating margin declined due to the lower volumes.

Direct operating cash flow for the Group amounted to SEK -1.6bn (-0.2), impacted by the planned reduction of trade receivables financing. We are actively focusing on our inventory levels, which continued to decrease.

Strategic progress 
We continue to deliver on our strategy. A key aspect of our transformation is to expand in segments such as robotic mowers, battery-powered products, watering and solutions for the professional market. Several innovative products within these areas were launched prior to the season and achieved strong growth. This includes new robotic mowers, both for residential users and professionals, chainsaw models, watering products and an expanded product range in the Husqvarna Construction Division.

Another strategic aspect is our commitment to sustainability. The Group's efforts to reduce its carbon footprint are developing well. To date, CO? emissions (Scope 1, 2 and 3) have decreased by -51% compared with the base year of 2015. This is driven by the electrification of our industry and lower sales of petrol-powered products, primarily wheeled. With that, we have exceeded our target of a -35% reduction by 2025. 

In summary, the sales trend improved gradually during the quarter and we achieved growth in the Gardena Division. We continue to build a stronger Group and to deliver on our strategic transformation. With a strong range of innovative products, we have a solid platform and are well positioned for the gardening season." 

Pavel Hajman, CEO

Webcast presentation and telephone conference
A webcast presentation of the Q1 report hosted by Pavel Hajman, CEO and Terry Burke, CFO will be held at 10:00 CET on April 24, 2024.

To view the presentation, please use the link: husqvarnagroup.creo.se/891cd80d-8cee-477f-9645-78b81c459fa2  

The dial-in to the telephone conference (in order to ask questions):
+46 (0) 8 505 100 31 (Sweden) or +44 207 107 06 13 (UK). 

Dates for Financial Reports 2024
July 18           Interim report for January-June 2024
October 23    Interim report for January-September 2024

Terry Burke, CFO and Executive Vice President, Finance, IR & Communication 
+46 8 738 90 00

Johan Andersson, Vice President, Investor Relations 
+46 702 100 451

Husqvarna AB (publ), P.O. Box 7454, SE-103 92 Stockholm
Regeringsgatan 28, +46 8 738 90 00, www.husqvarnagroup.com 

Reg. Nr: 556000-5331

This report contains insider information that Husqvarna AB is required to disclose under the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the contact person set out above, at 07.00 CET on April 24, 2024.

Factors affecting forward-looking statements
This report contains forward-looking statements in the sense referred to in the American Private Securities Litigation Reform Act of 1995. Such statements comprise, among other things, financial goals, goals of future business and financial plans. These statements are based on present expectations and are subject to risks and uncertainties that may give rise to major deviations in the result due to several aspects. These aspects include, among other things: consumer demand and market conditions in the geographical areas and lines of business in which Husqvarna operates, the effects of currency fluctuations, downward pressure on prices due to competition, a material reduction in sales by important distributors, success in developing new products and in marketing, outcome of product responsibility litigation, progress in terms of reaching the goals set for productivity and efficient use of capital, successful identification of growth opportunities and acquisition objects, integration of these into the existing business and successful achievement of goals for making the supply chain more efficient.

This information was brought to you by Cision http://news.cision.com


The following files are available for download:


Interim report Q1 2024 Husqvarna Group (PDF)

SOURCE Husqvarna Group

These press releases may also interest you

23 mai 2024
Today in Toronto, Heffel Fine Art Auction House hosted its highly-anticipated...

23 mai 2024
iStaging is an innovative Mixed Reality SaaS company driven by computer vision & AI, backed by 10 years of technological development and 100,000 corporate users around the world. iStaging joined VivaTech this year to showcase its new technological...

23 mai 2024
In an exclusive video interview with DIGITIMES Asia managing editor Judy Lin (JL), Marc Hijink (MH), the acclaimed Dutch journalist and author of "Focus - the ASML Way," during his visit to Taipei, Taiwan, delves into the intricate world of ASML, a...

23 mai 2024
Celltrion today announced that the European Commission (EC) has approved Omlyclo® (CT-P39), an omalizumab biosimilar referencing Xolair®. Omlyclo® is approved for the treatment of allergic asthma, chronic spontaneous urticaria (CSU), and chronic...

23 mai 2024
In the news release, IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal Melanoma, issued 23-May-2024 by IDEAYA Biosciences, Inc. over PR...

23 mai 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its four abstracts selected for presentations at the 2024...

News published on and distributed by: